Drug information for MINIRIN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SPRAY, METERED; NASAL
0.01MG/SPRAY
Prescription
AB (Reference Drug)
DESMOPRESSIN ACETATE
Deamino Arginine Vasopressin
FERRING
21333
2007-12-04 Other Important Information from FDA
2006-07-25 Review
2003-09-25 Letter
2003-09-25 Label
2002-09-16 Letter
2002-09-16 Label
Drug Adverse Effects information for MINIRIN
Role code
Indications
Reaction
# Reports
PS
DIABETES INSIPIDUS
ACTIVITIES OF DAILY LIVING IMPAIRED
1
PS
DIABETES INSIPIDUS
BLOOD SODIUM DECREASED
1
PS
DIABETES INSIPIDUS
DRUG ADMINISTRATION ERROR
1
PS
DIABETES INSIPIDUS
FATIGUE
1
PS
DIABETES INSIPIDUS
HYPERNATRAEMIA
1
PS
DIABETES INSIPIDUS
HYPONATRAEMIA
1
PS
DIABETES INSIPIDUS
LETHARGY
1
PS
DIABETES INSIPIDUS
MUSCLE SPASMS
2
PS
DIABETES INSIPIDUS
NAUSEA
1
PS
DIABETES INSIPIDUS
PYREXIA
1
PS
DIABETES INSIPIDUS
VISION BLURRED
2
PS
DIABETES INSIPIDUS
VOMITING
1
PS
ENURESIS
CONVULSION
2
PS
ENURESIS
ENCEPHALOPATHY
1
PS
ENURESIS
HYPONATRAEMIA
2
C
DYSTHYMIC DISORDER
AMNESTIC DISORDER
1
C
DYSTHYMIC DISORDER
ANTIPSYCHOTIC DRUG LEVEL INCREASED
1
C
ENURESIS
ATAXIA
2
C
ENURESIS
HEMIANOPIA
2
C
ENURESIS
HYPERTONIC BLADDER
2
C
ENURESIS
IMMUNE RECONSTITUTION SYNDROME
2
C
ENURESIS
MENINGITIS HERPES
2
C
ENURESIS
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
2
C
ENURESIS
SENSORY LOSS
2
C
ERECTILE DYSFUNCTION
ATAXIA
2
C
ERECTILE DYSFUNCTION
HEMIANOPIA
2
C
ERECTILE DYSFUNCTION
HYPERTONIC BLADDER
2
C
ERECTILE DYSFUNCTION
IMMUNE RECONSTITUTION SYNDROME
2
C
ERECTILE DYSFUNCTION
MENINGITIS HERPES
2
C
ERECTILE DYSFUNCTION
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
2
C
ERECTILE DYSFUNCTION
SENSORY LOSS
2
C
GROWTH HORMONE DEFICIENCY
HEADACHE
1
C
GROWTH HORMONE DEFICIENCY
PAIN IN EXTREMITY
1
C
GROWTH HORMONE DEFICIENCY
PYREXIA
1
C
MULTIPLE SCLEROSIS
ATAXIA
2
C
MULTIPLE SCLEROSIS
HEMIANOPIA
2
C
MULTIPLE SCLEROSIS
HYPERTONIC BLADDER
2
C
MULTIPLE SCLEROSIS
IMMUNE RECONSTITUTION SYNDROME
2
C
MULTIPLE SCLEROSIS
MENINGITIS HERPES
2
C
MULTIPLE SCLEROSIS
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
2
C
MULTIPLE SCLEROSIS
SENSORY LOSS
2
C
POSTOPERATIVE CARE
HAEMATOMA
1
C
POSTOPERATIVE CARE
HEPATIC ENZYME INCREASED
1
C
SCHIZOPHRENIA
AMNESTIC DISORDER
1
C
SCHIZOPHRENIA
ANTIPSYCHOTIC DRUG LEVEL INCREASED
1
Ads by Google